Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, pharmacokinetics and pharmacodynamics of oral PTH134 in postmenopausal women with osteoporosis; the study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• PTH134 (PTH134)

Snippet

Sponsor: Novartis | Conditions: Post-menopausal Osteoporosis | Phase 1 | Status: COMPLETED